Cannabidiol is a non-psychoactive substance present in cannabis. It is a beneficial therapeutic agent, although there is not much solid science that establishes just what cannabidiol can successfully treat. There are many health benefits of CBD, and add to these, the latest finding that taking an acute amount of it can reduce tremors in Parkinson’s disease.
The most carefully-researched therapeutic application of cannabidiol is in trying to heal epileptic seizures. CBD is traversing a time when it is fully not regulated, and it tends to be branded as an elixir for every form of incurable diseases. In 2019, the Food and Drug Administration tracked down numerous companies that sell cannabidiol with health claims not supported by evidence.
A more carefully-researched therapeutic implementation of cannabidiol relates to the substance’s remarkable anti-anxiety properties. One of Parkinson’s disease’s main non-motor signs is heightened anxiety. On a related note, a recent study by scientists in Brazil is reporting outcomes of the first placebo-controlled and randomized clinical test, which explores CBD’s effects on Parkinson’s patients’ anxiety.
“CBD modulates brain regions related to stress and anxiety,” says corresponding author of the research, Daiene de Morais Fabricio. “A neuroimaging study of healthy subjects showed that CBD reduces the effectiveness of the connection between the anterior cingulate cortex and the amygdala during the processing of stimuli that include fear-expressing facial expressions. These observations suggest that CBD may be an alternative treatment for PD and anxiety patients.”
This team of researchers had looked into the said effects on those with Parkinson’s, finding that the therapy considerably improved their emotional wellbeing and standard of health. However, the earlier research suggested cannabidiol did not make the tremors related to Parkinson’s better.
The new research aimed to find CBD’s effect on Parkinson’s-related anxiety in a more specific way, and whether the substance can ease tremors due to anxiety-causing scenarios. The test was done on many Parkinson’s patients. Every single person got a 300-milligram dose of cannabidiol or placebo, and 1½ hours later, they were part of an SPST (Simulated Public Speaking Test).
It is not surprising that the test revealed cannabidiol markedly eased the anxiety due to the SPST. May be more significantly, however, this treatment eased the magnitude of tremors caused by the said test. The Brazilian researchers suggest that it is expected to see that correction between eased anxiety and Parkinson’s tremors.